Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Ferroptosis and cancer prognosis, and Circular RNAs in diseases.
The Role of SLC7A11 in Tumor Progression and the Regulation Mechanisms Involved in Ferroptosis
Ciprofol suppresses glycolysis and EMT in colorectal cancer cells by activating APC to modulate the Wnt/β-catenin signaling pathway
The miR‐302/367 cluster: Aging, inflammation, and cancer
WITHDRAWN: Ciprofol Suppresses Glycolysis and Epithelial-Mesenchymal Transition (EMT) in Colorectal Cancer Cells by Activating Adenomatous Polyposis Coli to Modulate the Wnt/β- catenin Signaling Pathway
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing
Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer
Patient-Level DNA Damage Repair Pathway Profiles and Anti-Tumor Immunity for Gastric Cancer
Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy
Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses
M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p
Bioinformatics analysis of Ewing's sarcoma: Seeking key candidate genes and pathways
<scp><i>MARVELD1</i></scp> inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma